Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ZBH | Common Stock | Options Exercise | $818K | +11.5K | +27.51% | $70.97 | 53.4K | Dec 13, 2022 | Direct | F1, F2 |
transaction | ZBH | Common Stock | Sale | -$1.34M | -10.5K | -19.59% | $128.56 | 42.9K | Dec 13, 2022 | Direct | F1, F3 |
transaction | ZBH | Common Stock | Sale | -$137K | -1.06K | -2.48% | $129.34 | 41.9K | Dec 13, 2022 | Direct | F1, F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ZBH | Employee Stock Option (right to buy) | Options Exercise | $0 | -11.5K | -33.33% | $0.00 | 23K | Dec 13, 2022 | Common Stock | 11.5K | $70.97 | Direct | F1, F5 |
Id | Content |
---|---|
F1 | The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 29, 2022. |
F2 | Includes 341 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan and pursuant to dividend reinvestment between April 27, 2022 and October 31, 2022. |
F3 | Reflects the weighted average price of 10,459 shares of common stock of Zimmer Biomet Holdings, Inc. sold in multiple transactions on December 13, 2022 with sale prices ranging from $128.00 to 128.98 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuance, full information regarding the number of shares sold at each separate price. |
F4 | Reflects the weighted average price of 1,063 shares of common stock of Zimmer Biomet Holdings, Inc. sold in multiple transactions on December 13, 2022 with sale prices ranging from $129.02 to $129.90 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuance, full information regarding the number of shares sold at each separate price. |
F5 | Vested annually over four years in increments of 25% each year, commencing on March 18, 2014. |